Ozsoyler, IbrahimUcak, Haci AliBadak, Tolga OnurCakallioglu, AhmetBayraktar, MuhammetArslan, Ahmet Suha2024-11-072024-11-0720231301-5680https://doi.org/10.5606/tgkdc.dergisi.2023.24422https://search.trdizin.gov.tr/tr/yayin/detay/1176991https://hdl.handle.net/11480/15415Background: This study aims to examine the relationship between the development of coronary collateral circulation and serum elabela levels. Methods: Between January 2020 and December 2021, a total of 50 control individuals (29 males, 21 females; mean age: 63.2 +/- 10.0 years; range, 52 to 73 years) with no significant coronary artery disease as confirmed by angiography (Group 1) and 100 patients (55 males, 45 females; mean age: 66.6 +/- 9.6 years; range, 56 to 75 years) with coronary artery disease were included. The patients were further divided into two equal groups according to the Rentrop classification as poor (Group 2) and good coronary collateral circulation (Group 3). All groups were compared in terms of several parameters, particularly serum elabela levels. Results: Serum elabela levels were found to be statistically higher in the group with good collateral than the other groups (p<0.05). Low serum elabela levels increased the risk of developing weak collaterals by 2.43 times. Conclusion: The elabela protein is directly related to good collateral development and can be considered a potential agent for treatment.eninfo:eu-repo/semantics/openAccessApelinergic systemcoronary artery diseasecoronary collateralelabelaArticle31219219810.5606/tgkdc.dergisi.2023.24422374846412-s2.0-85158970063Q31176991WOS:000983239400008Q4